Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Proteins
|
November 6, 2023
A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface
Gayathri Mani, Serene El-Kamand, Bing Wang, et al.
Molecular Cancer
|
May 13, 2010
Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
Amanda L Cleaver, Alex H Beesley, Martin J Firth, et al.
British Journal of Haematology
|
February 28, 2008
Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index
Katrin Hoffmann, Martin J Firth, Alex H Beesley, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
December 17, 2008
Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines
David J Holthouse, Peter B Dallas, Jette Ford, et al.
British Journal of Haematology
|
April 26, 2007
Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia
Nicholas G Gottardo, Katrin Hoffmann, Alex H Beesley, et al.
Proteins
|
July 3, 2024
A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts
David L Baker, Bing Wang, Lorna E Wilkinson-White, et al.
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)
|
December 6, 2012
Do bib clips pose a cross-contamination risk at the dental clinic?
Addy Alt-Holland, Sreedevi Srinivasan, Rebekah Lucier, et al.
Blood
|
March 21, 2007
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi, Michelle J Henderson, Edward Kwan, et al.
The New England Journal of Medicine
|
October 1, 2010
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
David L Baker, Mary L Schmidt, Susan L Cohn, et al.
Pediatric Blood & Cancer
|
April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group
Steven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Proteins
|
November 6, 2023
A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface
Gayathri Mani, Serene El-Kamand, Bing Wang, et al.
Molecular Cancer
|
May 13, 2010
Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
Amanda L Cleaver, Alex H Beesley, Martin J Firth, et al.
British Journal of Haematology
|
February 28, 2008
Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index
Katrin Hoffmann, Martin J Firth, Alex H Beesley, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
December 17, 2008
Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines
David J Holthouse, Peter B Dallas, Jette Ford, et al.
British Journal of Haematology
|
April 26, 2007
Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia
Nicholas G Gottardo, Katrin Hoffmann, Alex H Beesley, et al.
Proteins
|
July 3, 2024
A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts
David L Baker, Bing Wang, Lorna E Wilkinson-White, et al.
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)
|
December 6, 2012
Do bib clips pose a cross-contamination risk at the dental clinic?
Addy Alt-Holland, Sreedevi Srinivasan, Rebekah Lucier, et al.
Blood
|
March 21, 2007
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi, Michelle J Henderson, Edward Kwan, et al.
The New England Journal of Medicine
|
October 1, 2010
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
David L Baker, Mary L Schmidt, Susan L Cohn, et al.
Pediatric Blood & Cancer
|
April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group
Steven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Page
of 3